Organon & Co | OGN - Cost Of Sales



Organon & Co reported $720M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Adcock Ingram Holdings ZAR 3.18B 115.21M Dec/2024
Bristol-Myers Squibb USD 3.37B 339M Jun/2025
Celltrion KRW 399.04B 120.81B Mar/2025
Cspc Pharmaceutical CNY 2.31B 299.94M Mar/2025
Divis Laboratories Ltd 10.68B 870M Jun/2025
Gilead Sciences USD 1.5B 39M Jun/2025
Glaxosmithkline GBP 2.16B 363M Jun/2025
Kangmei Pharma CNY 1.03B 35.75M Jun/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
Laboratorios Farma EUR 54.41M 97.64M Jun/2025
Malin Corporation EUR 15.4M 0 Dec/2020
Medical Developments International AUD 5.27M 2.92M Dec/2024
Merck USD 2.82B 53M Jun/2025
Novartis USD 3.32B 5M Jun/2025
Organigram Holdings CAD 44.65M 2.96M Jun/2025
Organon & Co USD 720M 48M Jun/2025
Pharma Mar EUR 2.78M 620K Jun/2025
Qiagen NV USD 199.25M 24.48M Jun/2025
Sartorius EUR 468.1M 16.1M Jun/2025
Sino Biopharmaceutical CNY 2.49B 353.34M Dec/2024
Tilray USD 149.73M 9.39M Nov/2024